NO may reflect increased expression of inducible NO synthase at the sites of inflammaBackground -The concentration of nitric oxide (NO) is increased in the exhaled tion, 10 suggesting that measurement of exhaled NO may provide a non-invasive means of moniair of patients with inflammation of the airways, suggesting that this may be a use-toring airway inflammation and its control with anti-inflammatory drugs. 11 Glucocorticoids inful measurement to monitor inflammation in diseases such as asthma. However, there hibit the expression of inducible NO synthase and both oral and inhaled glucocorticoids rehave been concerns that exhaled NO may be contaminated by the high con-duce the concentrations of exhaled NO in asthmatic patients. 12 13 Furthermore, when the dose centrations of NO derived from the upper airways, and that this may account for of inhaled steroids is reduced in controlled asthmatic patients, exhaled NO increases bedifferences in reported values of exhaled NO using different techniques. A study fore any fall in lung function or increase in asthma symptoms, suggesting that monitoring was performed, with argon as a tracer, to determine the extent of nasal con-of exhaled NO may be useful in assessing asthma control.
Research, Rochester, UK) with a sensitivity from 1 ppb to 100 ppm of NO, accuracy participated in the study. None had a history of respiratory or cardiovascular disease or was receiving long term medication. Spirometric measurements showed a mean forced expiratory volume in one second of 101 (3)% predicted.

We studied whether the nasal cavities and the pharynx were in communication during a slow single exhalation against resistance or during tidal breathing or breath holding by sampling the posterior pharynx whilst the nasal cavities were gently flushed with a gas mixture containing 4.8% argon (fig 1) . Argon was chosen The subjects were asked to produce four manoeuvres: (1) slow exhalation with a flow rate of 6 (0.09) l/min through the mouthpiece 200 ms to 90% of full scale), expiratory flow and pressure, and exhaled volume in real time. against a resistance of 3 (0.4) mm Hg; (2) unobstructed exhalation through the standard The analyser was fitted with a biofeedback display unit to provide visual guidance for the spirometric mouthpiece (27 mm inner diameter) with no resistance to exhalation as it is subject to maintain the pressure and exhalation flow within a certain range (3 (0.4) mm Hg and wider than an average trachea; (3) tidal breathing through the spirometric mouthpiece for 50 6 (0.09) l/min for end exhaled NO measurements), thus improving test repeatability seconds; (4) breath holding for 30 seconds.
NO, argon, and CO 2 concentrations in the and enhancing patient cooperation. Pressure created in the mouthpiece, and subsequently in exhaled air were measured simultaneously during exhalation against a resistance and tidal the reaction chamber, varied non-significantly and therefore caused negligible change (<0.1 breathing manoeuvres. Only argon and CO 2 concentrations were assessed during breath ppb) in NO readings. The sampling rate through the reaction chamber of the analyser holding. Each manoeuvre was repeated three times. The subjects were asked to make two was 250 ml/min for all measurements. The analyser was calibrated daily using NO-free cer-exhalations without resistance, separated by a single inhalation of ambient air. The nasal tified compressed air to set absolute zero followed by a certified concentration of NO in cavities were gently flushed (flow 2 l/min) with the gas mixture containing 4.8% argon, 15% nitrogen of 91 ppb and 500 ppb (British Oxygen Corporation Special Gases, Guildford, O 2 , 4.7% CO 2 , balanced with N 2 before and during exhalation. Fine tubing with 0.5 mm UK) and certified 5% carbon dioxide (BOC). The linearity was tested with 31 serial dilutions internal diameter was put into the posterior oropharynx at the level of the tonsils (local from 0.6 to 2500 ppb of the NO test gas. Repeated serial dilutions showed that observed anaesthetic was not required) to sample the posterior oropharyngeal mixed air (flow NO values obtained by the analyser varied linearly with the predicted NO values, and all 200 ml/min) directly into the mass spectrometer (Model MGA 200, Airspec Ltd, Biggin points fell along the line of identity. Ambient air NO level was recorded and the absolute Hill, UK) with an accuracy of ±0.1% for argon and CO 2 assessment. Mean values of zero was adjusted prior to all measurements.
For the end exhaled NO measurements sub-the three NO and argon concentrations were calculated. All the measurements were made jects exhaled slowly from total lung capacity (TLC) up to 30 seconds with an exhalation on the same day when the ambient, and therefore the exhaled argon concentration, were flow rate of 6 (0.09) l/min, bypassing the analyser and thus with a low resistance to flow. 0.9%. NO was sampled from a side arm attached to the mouthpiece. The mean value of the previous 100 measurements, acquired with an in- 
The statistical analyses used the Student's terval of 25 Hz, was taken from the point on the NO trace corresponding to the CO 2 reading paired t test for the comparison between the start and end of each exhalation, with the level of 5-6%. Results of the analyses were computed and graphically displayed on a plot of NO and of significance taken as 5%. CO 2 concentrations, pressure, and flow against time.
Results     Simultaneous measurements of NO and argon  Seven non-smoking, non-atopic normal sub-were made during the exhalation against a resistance. As the nasal cavities were flushed jects (five men) of mean (SD) age 30 (4) years group.bmj.com on April 12, 2017 -Published by http://thorax.bmj.com/ Downloaded from from the remainder of the respiratory tract by elevation of the soft palate due to positive back pressure, there was no increase in argon concentration (fig 2) . The mean argon concentration did not change during the exhalation: 0.91% (95% confidence interval (CI) 0.84% to 0.98%) at the start and 0.91% (95% CI 0.87% to 0.95%) at the end of exhalation (p >0.05). End exhaled NO levels were 6.3 (1.01) ppb.
Exhaled air measured during a single exhalation without resistance and with no back pressure was contaminated with argon derived from the nasal cavities due to soft palate opening at the start of exhalation (0.91% (95% CI 0.84% to 0.98%), increasing to 1.28% (95% CI 0.9% to 2.24%) at the end of the second exhalation (p <0.0001). Thus, in subjects breathing through the mouth freely, nasopharyngeal NO is added to the mouth exhalate which is reflected by an increase in argon concentration when compared with the ambient level of argon.
There was an increase in the argon concentration from 0.91% (95% CI 0.84 to 0.98%) to 2.37% (95% CI 2.29 to 2.5%) during tidal breathing (p <0.0001). NO levels were also significantly higher at the end of tidal breathing (7.2 (1.34) ppb compared with 3.2 (0.87) ppb at the beginning, p <0.001), presumably be-     Direct sampling of the argon concentration in the posterior pharynx during breath holding revealed complete closure of the soft palate. The CO 2 levels gradually increased up to 0.3-0.4% over 25-30 seconds of breath holding, reflecting the mixed air in the posterior pharynx. There was no increase in argon concentration throughout the breath hold from 0.91% (95% CI 0.84% to 0.98%) to 0.92% (95% CI 0.87% to 0.97%), p >0.05, except the small (0.1%) peak at the end of breath holding when the mass spectrometer sampling tube was removed from the mouth.
Discussion
There are three commonly used approaches to the measurement of exhaled NO: (1) collection of the exhaled air into a reservoir during tidal breathing or single exhalation with analysis thereafter; (2) sampling from a mixing chamber at the expiratory side of the mouthpiece during tidal breathing or via a side arm from the the mouthpiece with side arm sampling or directly into the analyser.
A reservoir collection method might be preferred for measurement of NO production at with argon prior to exhalation, the initial very short (no longer than 0.3-0.4 s) peaks of argon rest, during exercise, or when the chemiluminescence analyser is not available on site. (up to 0.5-0.8% above the baseline of 0.9% of ambient argon) and CO 2 (up to 0.4-0.5% It has been shown that the material of which the reservoirs are made (polyethylene or NO above the zero CO 2 baseline) were recorded immediately after placing the mass spectro-impermeable mylar) does not substantially affect the results. 20-22 Indeed, Schilling et al meter sampling tip into the mouth. Because the nose and nasopharynx were partitioned have shown no change in NO concentration group.bmj.com on April 12, 2017 -Published by http://thorax.bmj.com/ Downloaded from sampling with a flow rate of 250 ml/min during breath holding when the soft palate is closed. 18 Soft palate closure has been confirmed by the absence of CO 2 and argon traces in the nasal sample. High nasal levels have been obtained during direct binasal sampling whilst mouth breathing (394 (23) ppb) 25 and via a bronchoscope directly from the nasopharynx (334 (52) ppb), with a further increase to >1000 ppb during breath holding when the soft palate was closed. However, the use of an air stream of 2-5 l/min through the nose reduced nasal NO levels to 105 ppb during mouth breathing and 140 ppb whilst breath holding, 4 implying that there was a dilution due to the air stream application and a mixing of "high nasal NO" with "low exhaled NO".
At rest, release of NO from the nasal passages It is more likely that the presence and the extent of the nasal contribution depends upon the type of exhalation manoeuvre. Exhaled NO levels during tidal nasal breathing were 2-3 (5 ppb) in a polyethylene reservoir for up to 12 hours. 23 However, tidal breathing through the times higher than during mouth breathing. 4 22 During assisted ventilation via the nose exhaled mouth 22 23 appears to give higher NO values (14.2 (1.6) ppb and 18 (8) ppb, respectively) NO was four times higher than during spontaneous mouth breathing and 13 times lower than a single exhalation into a reservoir (6.2 (0.4) ppb). 24 As we have shown in our study, when any nasal contribution was completely abolished by spontaneous breathing via there is convincing evidence for a nasal contribution to the exhalate during tidal breathing tracheostomy. 25 There is a significant nasal contribution to exhaled NO in normal subjects because of soft palate opening. NO measured in exhaled air collected during tidal breathing whilst tidal breathing with noseclips in place.
22
As we have demonstrated, with simultaneous into a reservoir is therefore more likely to represent a mixture of nasal and exhaled NO, and NO and argon measurements in the exhaled breath there was an increase in argon coming this may diminish any changes that might occur in NO derived from the lower respiratory tract. from the nasal passages during a single exhalation without resistance or during tidal This nasal contribution may be the reason behind the poor reproducibility of the tech-breathing because of an opened soft palate.
However, the same measurements did not show nique involving sampling from a mixing chamber during tidal mouth breathing. Thus, any trace of argon in the exhaled air when the subjects were using the slow exhalation Persson et al reported that stable end expiratory NO could not be reached during tidal breathing manoeuvre against mild resistance (fig 4) . Back pressure created by exhalation against re-(6-12 l/min). 15 However, the same authors did detect NO in the mixing chamber during tidal sistance effectively kept the soft palate closed.
Indeed, when the nasal contribution to mouth breathing for 2-3 minutes but the method was not sensitive enough to detect the difference breathing was eliminated by voluntary soft palate closure or by applying the balloon occlusion between normal (8.4 (1.2) ppb) and asthmatic subjects (10.3 (3. 3) ppb) which has been shown method, exhaled NO from the mouth was reduced by half.
in other studies. 6 The most reproducible and similar results (8 Slow exhalation from vital capacity to residual volume through the mouthpiece, which (0.8) ppb, 7 (1) ppb and 7 (4) ppb) were obtained when exhaled NO was measured dur-inevitably creates resistance, appears to be the best manoeuvre to obtain the most reing a slow single exhalation through the mouthpiece with sampling via a side arm directly into producible NO samples, free of nasal contamination. Thus, using this technique several the analyser against mild resistance, causing soft palate closure, hence isolating nasal pas-groups have obtained exhaled NO values that are in good agreement: 7 (4) ppb, 22 7 (1) sages from the oropharynx. 1 19 22 There are two main approaches in nasal NO ppb, 19 and 6 (0.4) ppb, even though the latter was analysed from a reservoir. 24 Exhalation assessment: (1) direct sampling from the nose with an air stream generated by the analyser against resistance closes the soft palate, hence abolishing nasal contamination. Indeed, as whilst mouth breathing or breath holding; or (2) use of NO-free air stream infused into one Kimberley et al have shown, there was no difference in exhaled NO measured either durnostril at a certain flow rate and exited from the other nostril where it is analysed during ing slow exhalation against resistance (7 (4) ppb) or after the nasopharynx was isolated mouth breathing or breath holding. We have previously reported nasal NO levels of 996 (39) by inflated balloon occlusion (7 (4) ppb). 
